Evaluation of the Pneumonia plus panel for the identification of pathogens and modification of antibiotics in patients with lower respiratory infections at a tertiary centre
Not Applicable
- Conditions
- Health Condition 1: J180- Bronchopneumonia, unspecified organism
- Registration Number
- CTRI/2023/07/055679
- Lead Sponsor
- Aster Medcity Cochin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Broncho alveolar lavage specimens from patients admitted to our hospital with a diagnosis of lower respiratory tract infection
Exclusion Criteria
1 Repeat specimens from patients of whom a previous specimen was included
2 Patients who are terminally ill
3 Patients with no consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber or percentage of patients in whom clinical decisions were modified on molecular diagnostic panel resultsTimepoint: one hour
- Secondary Outcome Measures
Name Time Method 1 Causative agent & antibiotic susceptibility in pneumonia <br/ ><br>2 Time to positivity and 28 day mortalityTimepoint: 28 day mortality